Connect with us

Technology

Revenue cycle management (RCM) market size in US to grow by USD 11.98 billion from 2022 to 2027, Growing adoption of a value-based reimbursement model to be a major trend, Technavio

Published

on

NEW YORK, March 6, 2024 /PRNewswire/ — The revenue cycle management (RCM) market in the US is set to grow by USD 11,985.2 million from 2022 to 2027 progressing at a CAGR of 9.94% during the forecast period. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The growing need to reduce revenue leakages in healthcare systems drives market growth. There is an increased focus on reducing the growing revenue leakages to remain competitive in the market in focus from the market vendors in the healthcare service industry. Due to the additional time and resources needed in manual systems, revenue leaks cost more than using electronic systems. Furthermore, in the patient leak process, sometimes a healthcare service provider allows a patient to leave the care setting and sends statements to the patient later. This results in patient-level revenue leakage. Hence, owing to factors such as revenue leaks, the RCM market is estimated to grow during the forecast period. 

Here is an Exclusive report talking about Market scenarios with a historical period (2017-2021) and the forecast period (2023-2027). 

Download Sample Report in minutes!

Report Coverage

Details

Page number

127

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 9.94%

Market growth 2023-2027

USD 11,985.2 million

Market structure

Fragmented

YoY growth 2022-2023(%)

9.45

The growing adoption of a value-based reimbursement model 

There is a shift from fee-for-service to value-based care reimbursements in the healthcare service industry. Value-based RCM is a reimbursement payment methodology, focusing more on quality healthcare at a reasonable cost. Owing to the adoption of programs and legislation by various governments, the involvement of healthcare service providers across the world in value-based RCM models is rising. Hence, such initiatives are expected to have a positive impact on the adoption of value-based RCM, which will boost the growth of the RCM market in the US during the forecast period.

Interoperability issues associated with RCM solutions challenge the growth of the RCM market in US. 

Download Sample Report in minutes!

Market Segmentation

This US revenue cycle management (RCM) market report extensively covers market segmentation by product (software and services) and end-user (hospitals, physicians, and medical labs). 

The software segment will be significant during the forecast period. The growth of the segment can be attributed to factors such as the various software solutions that are specifically designed to streamline and automate the entire revenue cycle management (RCM) process. Furthermore, there are several vendors operating in the market that offer RCM as software solutions. For instance, Epic Systems Corporation offers an integrated suite of healthcare software solutions, including Epic Resolute, which is the company’s revenue cycle management software and they provide comprehensive RCM functionalities. Hence, owing to such factors, the software segment of the RCM market is estimated to grow during the forecast period.

This report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters

 View Sample Report

Companies Mentioned

Acclara Solutions LLCathenahealth Inc.CareCloud Inc.Change Healthcare Inc.Cognizant Technology Solutions Corp.Computer Programs and Systems Inc.eClinicalWorks LLCEpic Systems Corp.Experian PlcInternational Business Machines Corp.Koch Industries Inc.McKesson Corp.Medical Information Technology Inc.Oncospark Inc.Oracle Corp.OSPPlanet DDSR1 RCM Inc.Sage Group PlcThe SSI Group LLCVeradigm LLC

Vendor Oferings

Acclara Solutions LLC – The company offers revenue cycle management solutions such as Patient Access, Revenue Integrity and Coding, Business Office, and Community Provider Solution.athenahealth Inc. – The company offers revenue cycle management solutions such as athenaIDX for large practices, health systems, billing services, and hospitals.Change Healthcare Inc. – The company offers revenue cycle management solutions and services for healthcare providers including hospitals, health systems, physicians, and non-hospital emergency medical service providers to support cash flow, increase speed to payment, and contain costs at a faster rate.

Gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

Analyst Review

The US Revenue Cycle Management (RCM) market stands at the intersection of healthcare organizations’ financial health and patient care quality. It encompasses a suite of processes vital to the financial viability of healthcare providers, starting from patient registration and extending through claims processing and payment collection. In an era of burgeoning healthcare costs and evolving reimbursement models like value-based care, efficient RCM practices are paramount for sustainability.

In this landscape, artificial intelligence (AI) and machine learning (ML) are emerging as game-changers. Companies like FutureWise Research delve into the AI in Healthcare market, offering innovative solutions for workflow optimization and data security. However, as the digitalization of healthcare accelerates, concerns over data security and confidentiality loom large, especially with the proliferation of EHRs and health information exchanges.

These challenges are exacerbated by the threat of ransomware attacks, underscoring the need for robust data security measures. Amidst this backdrop, R1 RCM Inc. and other players offer RCM software solutions that integrate medical billing and coding with advanced AI algorithms to streamline processes and mitigate risks.

The market’s services segment is witnessing a surge, with providers increasingly outsourcing RCM solutions to specialized firms. These firms leverage machine learning algorithms for claims processing and insurance verification, enhancing efficiency and accuracy while reducing administrative burden.

However, the industry grapples with data siloes and fragmented systems, hindering seamless process digitalization. Companies are thus investing in patient management solutions that break down these barriers, enabling comprehensive patient registration and care coordination.

The transition to ICD-10 further underscores the need for agile RCM solutions capable of adapting to evolving coding standards. Future growth prospects lie in emerging markets, where demand for RCM services is burgeoning, fueled by increasing healthcare expenditure and regulatory reforms.

In essence, the US RCM market is undergoing a transformative shift driven by technological innovation and evolving healthcare dynamics. Companies that navigate this landscape adeptly, harnessing the power of AI and data analytics while prioritizing data security and compliance, are poised to thrive in this dynamic ecosystem. 

View Sample Report

Related Reports:
The telecom billing revenue management market size is estimated to grow at a CAGR of 8.73% between 2022 and 2027. The telecom billing revenue management market size is forecast to increase by USD 6.99 billion. This telecom billing revenue management market report extensively covers market segmentation by solution (software and services), deployment (on-premise and cloud), and geography (North America, Europe, APAC, South America, and Middle East and Africa). The expanding telecom services are notably driving the market growth.

The innovation management market size is estimated to grow at a CAGR of 10.3% between 2022 and 2027. The market size is forecast to increase by USD 774.63 million.This innovation management market report extensively covers market segmentation by component (services and solutions), deployment (cloud-based and on-premises), and geography (North America, Europe, APAC, South America, and the Middle East and Africa). Growth in infrastructure development is the key driver notably driving the growth of the global innovation management market.

Key Topics Covered:

1 Executive Summary
2 Landscape
3 Sizing
4 Historic Size
5 Five Forces Analysis
6 Segmentations
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Vendor Landscape
11 Vendor Analysis
12 Appendix

About US
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/revenue-cycle-management-rcm-market-size-in-us-to-grow-by-usd-11-98-billion-from-2022-to-2027–growing-adoption-of-a-value-based-reimbursement-model-to-be-a-major-trend-technavio-302080926.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

MATSON ANNOUNCES ADDITION OF 3 MILLION SHARES TO EXISTING SHARE REPURCHASE PROGRAM AND QUARTERLY DIVIDEND OF $0.36 PER SHARE

Published

on

By

HONOLULU, April 23, 2026 /PRNewswire/ — The Board of Directors of Matson, Inc. (NYSE: MATX), a leading U.S. carrier in the Pacific, approved adding three million shares to its existing share repurchase program and extending the program to December 31, 2029.  As of April 23, 2026, the existing share repurchase program had approximately 0.7 million shares remaining.  The Board also declared a second quarter dividend of $0.36 per common share.  The dividend will be paid on June 4, 2026 to all shareholders of record as of the close of business on May 7, 2026.

“We are pleased to announce an additional three million shares to our existing share repurchase program,” said Matt Cox, Matson’s Chairman and Chief Executive Officer.  “Since we commenced our share repurchase program in August 2021, we have repurchased approximately 14.3 million shares, or approximately 33% of the then outstanding shares, for a total cost of $1.3 billion.  Going forward, we will continue to be both disciplined and opportunistic in our capital allocation, and we remain committed to returning excess cash to shareholders to create additional shareholder value over the long-term.” 

Shares will be repurchased in the open market from time to time at the Company’s discretion, based on ongoing assessments of the capital needs of the business, the market price of its common shares and general market conditions.  The Company may enter into Rule 10b5-1 plans to facilitate purchases under the program.  The repurchase program may be suspended or discontinued at any time.

About the Company

Founded in 1882, Matson (NYSE: MATX) is a leading provider of ocean transportation and logistics services.  Matson provides a vital lifeline of ocean freight transportation services to the domestic non-contiguous economies of Hawaii, Alaska, and Guam, and to other island economies in Micronesia.  Matson also operates premium, expedited services from China to Long Beach, California, which includes cargo from other Asia origins, provides services to Okinawa, Japan and various islands in the South Pacific, and operates an international export service from Alaska to Asia.  The Company’s fleet of owned and chartered vessels includes containerships, combination container and roll-on/roll-off ships and barges.  Matson Logistics, established in 1987, extends the geographic reach of Matson’s transportation network throughout North America and Asia.  Its integrated logistics services include rail intermodal, highway brokerage, warehousing, freight consolidation, supply chain management, and freight forwarding to Alaska.  Additional information about the Company is available at www.matson.com.

Forward Looking Statements

Statements in this news release that are not historical facts are “forward-looking statements,” within the meaning of the Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties that could cause actual results to differ materially from those contemplated by the relevant forward-looking statement, including but not limited to, statements about capital allocation plans, the timing, manner and volume of repurchases of common shares pursuant to the repurchase program, and use of excess cash.  These forward-looking statements are not guarantees of future performance.  This release should be read in conjunction with our Annual Report on Form 10-K and our other filings with the SEC through the date of this release, which identify important factors that could affect the forward-looking statements in this release.  We do not undertake any obligation to update our forward-looking statements.

View original content to download multimedia:https://www.prnewswire.com/news-releases/matson-announces-addition-of-3-million-shares-to-existing-share-repurchase-program-and-quarterly-dividend-of-0-36-per-share-302752377.html

SOURCE Matson, Inc.

Continue Reading

Technology

Accord Specialty Pharmacy Named Finalist in MMIT’s 11th Annual Retail Specialty Pharmacy Patient Choice Awards

Published

on

By

ORLANDO, Fla., April 23, 2026 /PRNewswire/ — Accord Specialty Pharmacy, an independent specialty pharmacy serving patients across multiple states, has been named a finalist in the MMIT Patient Choice Awards, a recognition based on patient-reported satisfaction and experience.

Accord was selected as the only independent pharmacy among finalists in its category, alongside national pharmacy organizations such as Walgreens Specialty Pharmacy and Walmart Specialty Pharmacy. This distinction highlights the company’s commitment to delivering personalized, high-touch care for patients managing complex and chronic conditions.

The MMIT Patient Choice Awards recognize specialty pharmacies that demonstrate excellence in patient satisfaction, service quality, and overall care experience. Finalists are determined based on direct patient feedback, making the recognition a meaningful reflection of the trust patients place in their pharmacy providers.

“Being recognized alongside national organizations and as the only independent finalist validates our belief that personalized, patient-centered care drives better outcomes. We are building a model that combines clinical depth, national reach, and operational flexibility to better serve patients, providers, and partners.” said AJ Patel, Founder and Pharmacy Manager of Accord Specialty Pharmacy.

Accord Specialty Pharmacy supports patients across complex specialty categories, including oncology, rare disease, and infusion, through a clinically driven, high-touch care model designed to improve access, adherence, and outcomes. The company’s approach emphasizes personalized support, responsive care coordination, and strong clinical engagement to help patients navigate complex therapies more effectively. With a growing national footprint and multi-state licensure, Accord is positioned to support patients, providers, and partners across diverse markets.

For more information, visit MMIT Announces Finalists of the 11th Specialty Pharmacy Patient Choice Awards – MMITNetwork.

About Accord Specialty Pharmacy:

Accord Specialty Pharmacy is an ACHC-accredited, multi-state licensed independent specialty pharmacy located in Central Florida, dedicated to delivering high-quality, patient-centered care for individuals managing complex and chronic conditions. Through personalized support, clinical expertise, and a high-touch approach, Accord helps patients navigate every step of their treatment journey. Learn more at www.accordspecialty.com.

CONTACT: contact@accordspecialty.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accord-specialty-pharmacy-named-finalist-in-mmits-11th-annual-retail-specialty-pharmacy-patient-choice-awards-302752327.html

SOURCE Accord Specialty

Continue Reading

Technology

HAIVISION ANNOUNCES VOTING RESULTS FROM 2026 ANNUAL MEETING OF SHAREHOLDERS

Published

on

By

MONTRÉAL, April 23, 2026 /CNW/ – Haivision Systems Inc. (“Haivision” or the “Company”) (TSX: HAI) is pleased to announce the voting results from its annual meeting of shareholders held today in a virtual format.

A total of approximately 45.97 % of the issued and outstanding common shares of Haivision were represented at the meeting.

Election of Directors

Each of the six nominated directors of Haivision was elected as director of the Company with the following results:

Director

Votes
For

% Votes
For

Votes
Against

% Votes
Against

Miroslav Wicha

11,110,245

99.26 %

82,583

0.74 %

Harvey Bienenstock

11,155,137

99.66 %

37,691

0.34 %

Robin M. Rush

11,121,855

99.37 %

70,973

0.63 %

Neil Hindle

10,794,005

96.44 %

398,823

3.56 %

Julie Tremblay

10,941,969

97.76 %

250,859

2.24 %

Lee K. Levy II

9,084,418

81.16 %

2,108,410

18.84 %

2.   Appointment of Auditors

Deloitte LLP were reappointed auditors of the Company for the ensuing year with 12,492,582 (98.84%) votes cast in favour and 146,406 (1.16%) votes withheld.

3.   Approval of the Unallocated Awards under the Company’s Equity Incentive Plan

The Company’s unallocated awards were approved with 8,710,347 (77.82%) votes cast in favour and 2,482,481 (22.18%) votes cast against.

4.   Reapproval of Company’s Shareholder Rights Plan

The Company’s shareholder rights plan was approved with 10,572,490 (94.46%) votes cast in favour and 620,338 (5.54%) votes cast against.

Final voting results on all matters voted on at the meeting will be filed under Haivision’s profile on SEDAR+ at www.sedarplus.ca.

About Haivision

Haivision is a leading global provider of mission-critical, real-time video streaming and visual collaboration solutions. Our connected cloud and intelligent edge technologies enable organizations globally to engage audiences, enhance collaboration, and support decision making. We provide high quality, low latency, secure, and reliable live video at a global scale. Haivision open sourced its award-winning SRT low latency video streaming protocol and founded the SRT Alliance to support its adoption. Awarded four Emmys® for Technology and Engineering from the National Academy of Television Arts and Sciences, Haivision continues to fuel the future of IP video transformation. Founded in 2004, Haivision is headquartered in Montreal and Chicago with offices, sales, and support located throughout the Americas, Europe, and Asia. Learn more at haivision.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/haivision-announces-voting-results-from-2026-annual-meeting-of-shareholders-302752318.html

SOURCE Haivision Systems Inc.

Continue Reading

Trending